In this article, we examine the 12 Best Falling Stocks to Buy Now.
Market pullbacks can create opportunities for investors willing to look beyond short-term volatility. Warren Buffett famously advised, “Be fearful when others are greedy, and greedy when others are fearful.” The Kobeissi Letter, a market commentary firm, echoed this sentiment in a recent post on X, noting: “Bear markets are the best opportunity to acquire long-term equity investments.”
In early 2025, bearish sentiment was widespread. In March, Goldman Sachs cut its year-end forecast for the S&P 500 to around 6,200 from a previous 6,500, citing mounting tariff risks, slower GDP growth, and rising economic uncertainty. By July, however, the outlook had improved, and Goldman raised its 12-month target to roughly 6,900.
“The forecast change reflects our economists’ projections of earlier and deeper rate easing from the Fed, lower bond yields, continued strength in the largest stocks, and investors’ willingness to tolerate near-term weakness in company earnings,” the bank said.
Still, this optimism has not been shared equally across the market. David Kostin, Goldman Sachs’ chief U.S. equity strategist, recently (on August 8) noted that the U.S. market is experiencing its highest level of stock-level differentiation in three decades. As of August 8, the S&P 500 was up 8% year-to-date and just 1% below its all-time high, yet the median stock remained 12% below its 52-week peak.
Many of these lagging names have seen selective downturns, often driven by sector rotation, earnings misses, or external shocks rather than structural weakness. This post identifies 12 such stocks that could offer attractive entry points at current levels.
Nonwarit/Shutterstock.com
Our Methodology
To identify the 12 Best Falling Stocks to Buy Now, we began by screening (using Finviz and Yahoo Finance stock screeners) for the largest publicly traded companies whose share prices had declined by at least 35% year-to-date as of August 12, 2025. Next, we used the screener to aggregate a list of companies with an upside potential of at least 20%. We narrowed down to the 12 stocks that are the most popular among elite hedge funds, sourced from Insider Monkey’s Q1 2025 database. The list is ranked in ascending order of the number of hedge fund holders.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Best Falling Stocks to Buy Now
12. Molina Healthcare, Inc. (NYSE:MOH)
Number of Hedge Fund Holders: 38
Year-To-Date Returns: -47.15%
Analyst Upside Potential: 36.79%
Molina Healthcare, Inc. (NYSE:MOH) is one of the best falling stocks to buy now. On July 24, Cantor Fitzgerald reiterated its “Overweight” rating on Molina with a price target of $312. The reaffirmation came after Molina revised its 2025 guidance.
Cantor Fitzgerald highlighted concerns about the Health Insurance Exchange (HIX) business, noting that Molina’s 2025 HIX Medical Loss Ratio (MLR) guidance increased by 510 basis points to 85.1%. The analysts stated that the MLR guidance suggests that the HIX product line may operate at “break-even to negative low-single-digit margins,” compared to Elevance Health’s estimated 2-3% margins. Nonetheless, the firm noted that the revised guidance aligns more closely with investor expectations, especially after Elevance Health’s comments, which should provide more stability for Molina’s stock.
Cantor Fitzgerald stated that new uncertainties emerged during the second quarter of 2025. This includes challenges in determining “clean numbers” (excluding one-time SG&A benefits) and understanding why Molina’s Medicare MLR increased by 100 basis points. The firm pointed out that Molina’s Medicare book primarily consists of dual-eligible beneficiaries, which may explain the discrepancy.
Molina Healthcare, Inc. (NYSE:MOH) is an American managed care company. It provides health insurance services through government-sponsored programs, including Medicaid, Medicare, and state health insurance marketplaces. The company operates locally run health plans in more than 21 U.S. states, serving approximately 5.8 million members.
11. Dow Inc. (NYSE:DOW)
Number of Hedge Fund Holders: 43
Year-To-Date Returns: -47.99%
Analyst Upside Potential: 32.53%
Dow Inc. (NYSE:DOW) is one of the best falling stocks to buy now. On August 5, Rothschild Redburn raised Dow stock from a “Neutral” to a “Buy” rating. The firm also revised its price target downward from $65 to $40. Rothschild Redburn cited “relatively higher cyclical upside potential” for Dow compared to competitor Lyondell, which the firm said was driven by expectations of recovering polyethylene margins while polypropylene margins remain low.
The firm noted that Dow’s recent dividend cut, reducing the quarterly dividend by 50% to 35 cents per share, reset its capital allocation strategy. This action provided flexibility for debt repayment and a new share buyback program. Rothschild Redburn described Dow’s stock as being at a “trough free cash flow-based valuation” and below mid-cycle and replacement cost levels, and the firm sees the stock as offering an attractive risk/reward profile.
Dow Inc. (NYSE:DOW) is a global materials science company. It manufactures and markets performance chemicals, industrial intermediates, and plastics used in packaging, infrastructure, mobility, and consumer applications. Through its Packaging & Specialty Plastics segment, Dow supplies polyethylene and other ethylene derivatives critical to modern agriculture, including crop protection packaging, greenhouse films, and irrigation components.
10. Lululemon Athletica, Inc. (NASDAQ:LULU)
Number of Hedge Fund Holders: 48
Year-To-Date Returns: -51.25%
Analyst Upside Potential: 46.83%
Lululemon Athletica, Inc. (NASDAQ:LULU) is one of the best falling stocks to buy now. On July 24, Evercore ISI lowered its price target for Lululemon Athletica from $320 to $265, while maintaining an Outperform rating. The firm also removed Lululemon from its Top 5 Outperform list, replacing it with Ulta Beauty (NASDAQ:ULTA).
Evercore has trimmed its earnings outlook for Lululemon, lowering Q2 EPS to $2.95 from $3.00—still above the Street’s $2.88 consensus—and reducing global same-store sales growth expectations to 3.3% from 3.7%. For FY2025, EPS was revised down to $14.50 from $14.90, with same-store sales growth now projected at 3% instead of 4%, and gross margins expected to decline 130 basis points to 57.9%. FY2026 EPS was also cut to $15.85 from $16.70, slightly above the consensus of $15.58, as Evercore flagged concerns over Lululemon’s long-term growth trajectory.
Lululemon Athletica, Inc. (NASDAQ:LULU) is a Canadian athletic apparel company. It designs and sells performance wear, accessories, and footwear for activities such as yoga, running, and training. The company operates over 760 stores across North America, Asia, and Europe, and maintains a strong direct-to-consumer presence through its e-commerce platform.
9. Wix.com Ltd. (NASDAQ:WIX)
Number of Hedge Fund Holders: 50
Year-To-Date Returns: -46.20%
Analyst Upside Potential: 75.94%
Wix.com Ltd. (NASDAQ:WIX) is one of the best falling stocks to buy now. On August 11, the company announced an increase to its share repurchase program by an additional $200 million. This move expands the total authorized repurchase capacity to $500 million. Of the previously authorized $400 million, $100 million had already been utilized before this expansion.
Since the beginning of 2025, Wix has repurchased $300 million of its ordinary shares as part of this program. The repurchase program allows Wix to buy back its ordinary shares and/or convertible notes through various methods, including open market purchases, privately negotiated transactions, and plans compliant with U.S. securities laws and regulations. The program is flexible. It does not obligate Wix to acquire any specific amount of securities and can be suspended or discontinued at the company’s discretion.
The additional $200 million repurchase authorization will be implemented subject to Israeli legal requirements. This includes a 30-day period during which creditors may object to the repurchase plan as per Israeli company regulations.
Wix.com Ltd. (NASDAQ:WIX) is an Israeli software company. It operates a cloud-based platform that enables users to create, manage, and grow websites and digital experiences without coding. The company serves over 250 million registered users globally through products like Wix Editor, Wix Studio, and Velo, a no-code/low-code development environment.
8. Gartner, Inc. (NYSE:IT)
Number of Hedge Fund Holders: 51
Year-To-Date Returns: -53.36%
Analyst Upside Potential: 24.79%
Gartner, Inc. (NYSE:IT) is one of the best falling stocks to buy now. On August 5, the company released its Q2 2025 earnings, reporting adjusted earnings per share (EPS) of $3.53, beating the analyst consensus estimate by $0.23. The adjusted EPS was 9.6% higher than in the same quarter of the previous year. Quarterly revenue reached $1.7 billion, slightly above the consensus estimate of $1.68 billion, and a 5.7% year-over-year increase.
The company posted growth across its business segments. The Insights segment (formerly Research) generated $1.319 billion in revenue, up 4.2% year-over-year; the Conferences segment’s revenue touched $211 million, up 13.6% y-o-y; and the Consulting segment generated $156 million in revenue, an 8.8% increase y-o-y. Gross contribution margins for these segments were 74.5% for Insights, 40.3% for Consulting, and 33.2% for Conferences.
Gartner revised its full-year 2025 revenue guidance downward to at least $6.46 billion from a prior outlook of $6.54 billion, below analyst estimates of $6.57 billion. The company’s stock declined sharply (around 27-29%) after the report due to concerns about lowered full-year revenue guidance.
Gartner, Inc. (NYSE:IT) is an American research and advisory company. It provides expert insights, consulting services, and executive events that help organizations make informed decisions across technology, digital transformation, and business strategy. The company operates through three segments: Insights, Conferences, and Consulting, serving clients in over 100 countries.
7. Align Technology, Inc. (NASDAQ:ALGN)
Number of Hedge Fund Holders: 52
Year-To-Date Returns: -35.34%
Analyst Upside Potential: 39.78%
Align Technology, Inc. (NASDAQ:ALGN) is one of the best falling stocks to buy now. On August 5, the company announced plans to buy back $200 million of its common stock through open-market transactions. This repurchase is part of Align’s broader $1.0 billion stock repurchase program, which the Board approved in April this year. The company stated further that the program will be financed with its cash on hand.
The timing and number of shares repurchased will depend on various factors, including market conditions, stock price, trading volume, general business conditions, and capital availability. Align’s management anticipates that the program will be completed by January 2026.
John Morici, Align’s CFO, stated that the decision to repurchase stock reflects management’s and the Board’s confidence in Align’s long-term strategy and market opportunity. He added that the decision highlights the strength of the company’s balance sheet and its ability to generate cash.
Align Technology, Inc. (NASDAQ:ALGN) is an American medical device company. It designs and manufactures Invisalign clear aligners, iTero intraoral scanners, and dental CAD/CAM software for orthodontic and restorative treatments. The company serves over 230,000 Invisalign-trained dentists and orthodontists globally and has treated more than 14 million patients since launch.
6. Novo Nordisk A/S (NYSE:NVO)
Number of Hedge Fund Holders: 60
Year-To-Date Returns: -42.03%
Analyst Upside Potential: 36.76%
Novo Nordisk A/S (NYSE:NVO) is one of the best falling stocks to buy now. On August 7, HSBC maintained a “Hold” rating on Novo Nordisk and lifted the price target to 355 Danish Krone (DKK) from DKK340. HSBC increased the price target because it raised its estimates for the market share of oral semaglutide. Semaglutide is a pill that helps people with type 2 diabetes or obesity manage their condition. Novo Nordisk sells oral semaglutide for diabetes under the brand name Rybelsus.
HSBC projects that peak sales for the drug could exceed DKK15 billion ($2.34 billion) after 2034. The bank kept the “Hold” rating on the stock due to “ongoing concerns about market size” and “overhang compounders.” The analysts identified a potential “upside” for the stock if there is a recovery in Wegovy prescriptions in the U.S.
Novo Nordisk A/S (NYSE:NVO) is a Danish global healthcare company. It develops and manufactures pharmaceutical products for chronic diseases, with a primary focus on diabetes, obesity, and rare blood and endocrine disorders. The company’s portfolio includes GLP-1 therapies, such as Ozempic and Wegovy, as well as insulin and growth hormone treatments.
5. The Trade Desk, Inc. (NASDAQ:TTD)
Number of Hedge Fund Holders: 61
Year-To-Date Returns: -54.76%
Analyst Upside Potential: 41.77%
The Trade Desk, Inc. (NASDAQ:TTD) is one of the best falling stocks to buy now. On August 11, Jefferies downgraded The Trade Desk shares from a “Buy” rating to “Hold” and cut its price target from $95 to $50. Jefferies cited a sharper-than-expected slowdown in revenue growth.
On August 7, The Trade Desk reported its Q2 2025 earnings, where revenue came in at $694 million. This is a 19% year-over-year increase, but down 25% compared to the previous quarter, and below the expected 22% growth rate.
Jefferies noted that The Trade Desk faces increased competition, particularly from Amazon (NASDAQ:AMZN), which secured content deals with Roku (NASDAQ:ROKU) and Walt Disney (NYSE:DIS). The analysts pointed to this fact as one of the factors contributing to The Trade Desk’s slowdown in Q2 2025. The firm cited additional pressures, including advertisers shifting budgets to the first quarter to avoid tariff-related uncertainty, senior management changes, a major company reorganization, and a slower-than-expected rollout of The Trade Desk’s new Kokai platform.
Jefferies described The Trade Desk’s third-quarter revenue forecast of “at least 14% growth” as weak, especially compared to solid results from other advertising firms. Accordingly, the firm reduced its adjusted EBITDA estimates for 2025 and 2026 by 1% and 6%, respectively.
The Trade Desk, Inc. (NASDAQ:TTD) is an American technology company. It provides a cloud-based, self-service platform that enables advertisers to plan, buy, and optimize digital ad campaigns across various channels, including connected TV (CTV), display, audio, and mobile.
4. HubSpot, Inc. (NYSE:HUBS)
Number of Hedge Fund Holders: 61
Year-To-Date Returns: -39.61%
Analyst Upside Potential: 62.86%
HubSpot, Inc. (NYSE:HUBS) is one of the best falling stocks to buy now. On August 7, Piper Sandler upgraded HubSpot shares from “Neutral” to “Overweight” and raised its price target from $645 to $675. Piper Sandler cited HubSpot’s “better-than-feared” second-quarter performance.
HubSpot reported Q2 2025 financial results on August 6 and posted $760.9 million in total revenue, up 19% y-o-y. Income from the Professional services & other segment led the charge, surging 21% y-o-y to $16.3 million, while Subscription revenue reached $744.5 million, up 19%. The total revenue beat Piper Sandler’s projections by $22 million, although $5 million of the beat was attributed to foreign exchange.
Piper Sandler’s analysts see “early signs of a product-led turnaround”, which catalyzed the rating upgrade. The firm also pointed to a rebound in HubSpot’s core Americas market, with revenue growth increasing to 18.4% from 17.1% in the prior quarter. The company added 9,724 new customers, exceeding its guidance. It showed improvements in customer retention and multi-product adoption, with “42% of annual recurring revenue now coming from customers using three or more products.”
HubSpot, Inc. (NYSE:HUBS) is an American software company. It provides a cloud-based customer relationship management (CRM) platform that includes tools for marketing automation, sales enablement, customer service, and content management. The company serves over 258,000 customers globally, primarily small and mid-sized businesses, through products such as Marketing Hub, Sales Hub, and Service Hub.
3. Deckers Outdoor Corporation (NYSE:DECK)
Number of Hedge Fund Holders: 63
Year-To-Date Returns: -50.53%
Analyst Upside Potential: 29.28%
Deckers Outdoor Corporation (NYSE:DECK) is one of the best falling stocks to buy now. On July 27, Truist Securities raised its price target on Deckers Outdoor stock from $130 to $145. The firm maintained its Buy rating on the shares. Truist cited the strong performance of the HOKA brand as the reason for the target price bump.
Deckers reported Q1 2026 earnings on July 24, posting quarterly revenue of $965 million, 17% higher than the same quarter in FY 2025. The standout performance was Deckers’ HOKA brand, whose net sales increased 19.8% y-o-y to $653.1 million. Truist stated that HOKA rebounded with solid growth in wholesale and international markets. Also, direct-to-consumer (DTC) clarity is improving from previous trough levels.
Truist noted that Deckers’ management has not experienced pushback on higher prices. As a result, sell-out trends outpaced inventory sell-in despite the brand’s expanding presence. The firm also noted that while some of the first quarter’s outperformance was due to timing, second-quarter expectations align with consensus, with the potential to beat given Deckers’ conservative management approach.
Deckers Outdoor Corporation (NYSE:DECK) is an American footwear and apparel company. It designs, markets, and distributes lifestyle and performance products under brands including UGG, HOKA, Teva, Sanuk, and Koolaburra. The company sells through direct-to-consumer channels and wholesale partners.
2. Fiserv, Inc. (NYSE:FI)
Number of Hedge Fund Holders: 72
Year-To-Date Returns: -35.63%
Analyst Upside Potential: 43.34%
Fiserv, Inc. (NYSE:FI) is one of the best falling stocks to buy now. On July 7, Bernstein SocGen Group lowered its price target on Fiserv from $214 to $205 and maintained its “Outperform” rating on the stock. The firm cited the negative impact of Fiserv’s operations in Argentina, which Bernstein estimates reduced revenue growth and margins by 1-3 percentage points each in Q2 2025.
This impact relates to lower interest rates and high-margin pressures specific to the Argentine market. Bernstein highlighted that operating expenses (OpEx) grew about $120 million above usual patterns. About $40 million of the OpEx growth was attributed to acquisitions, and the remainder to increased distribution and investment costs.
Bernstein noted that despite these headwinds, Fiserv’s revenue growth remains healthy at approximately 6.7% year-over-year. The firm expressed caution about Fiserv’s second-half 2025 outlook, stating the numbers might not be fully de-risked. Benefits from newer initiatives and stable macroeconomic factors (including prepayment business and Argentina) could provide a 3-4 percentage point lift to revenues.
Fiserv, Inc. (NYSE:FI) is an American financial technology company. It provides payment processing, digital banking, and financial services solutions to banks, credit unions, merchants, and government institutions. The company operates through platforms such as Clover for point-of-sale systems and offers services including card issuing, account processing, fraud protection, and real-time payments.
1. UnitedHealth Group Incorporated (NYSE:UNH)
Number of Hedge Fund Holders: 139
Year-To-Date Returns: -50.11%
Analyst Upside Potential: 23.89%
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best falling stocks to buy now. On August 5, Piper Sandler reiterated its “Overweight” rating on UnitedHealth, while keeping the price target unchanged at $280 per share. Piper Sandler’s reiteration followed a group investor meeting with UnitedHealth leadership, where management addressed the company’s 2025 challenges with “humility and transparency.”
During the meeting, UnitedHealth outlined multi-year remediation plans that will begin in 2026. The plans will focus on actuarial conservatism and strategic planning. Piper Sandler projects that these efforts will support high-single-digit organic growth in earnings over the long term. In Piper Sandler’s opinion, UnitedHealth has “correctly diagnosed its problems” and laid out a “coherent, multi-dimensional path to remediation.”
UnitedHealth Group Incorporated (NYSE:UNH) is an American diversified healthcare company. It provides health benefits and services through its UnitedHealthcare and Optum segments, which include insurance coverage, pharmacy care, data analytics, and clinical services.
While we acknowledge the potential of UnitedHealth Group Incorporated (NYSE:UNH) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 12 Best Copper Stocks to Buy According to Hedge Funds and 10 Best EV Penny Stocks to Buy According to Hedge Funds.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
